In this section read our press releases, press coverage and published studies.
Heru, Inc. comes out of stealth mode to announce the development of a novel artificial intelligence (AI) driven vision diagnostic and augmentation...
BioWorld, Heru registers AI vision test with FDA, begins commercialization pilot, December 28, 2020
Ophthalmology360, Medical technology company Heru, Inc completes FDA registration following a $2.7M seed round, December 22, 2020
Ophthalmology Times, Cloud-based augmented/virtual reality platform receives class I listing with FDA, December 21, 2020
Images, a publication of Bascom Palmer Eye Institute, “Artificial Intelligence and Vision”, January, 2020
ARVO Annual Meeting, “Digital Glasses for Visual Rehabilitation of Glaucoma Patients suffering from Visual Fields Defects”, July, 2019
American Journal of Ophthalmology, “Toward Improving the Mobility of Patients with Peripheral Visual Field Defects with Novel Digital Glasses”, October 10, 2019
American Journal of Ophthalmology, “Expansion of peripheral Visual Field with Novel Virtual Reality Digital Spectacles”, October 15, 2019
ARVO Annual Meeting, “The effect of see-through digital spectacles on eye scanning behavior of patients with peripheral visual field losses”, June, 2020
PLoS One, “Mobility improvement of patients with peripheral visual field losses using novel see-through digital spectacles”, October 14, 2020